Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
282.86
-12.50 (-4.23%)
At close: May 14, 2025, 4:00 PM
286.40
+3.54 (1.25%)
After-hours: May 14, 2025, 5:27 PM EDT
Madrigal Pharmaceuticals Employees
Madrigal Pharmaceuticals had 528 employees as of December 31, 2024. The number of employees increased by 152 or 40.43% compared to the previous year.
Employees
528
Change (1Y)
152
Growth (1Y)
40.43%
Revenue / Employee
$601,104
Profits / Employee
-$741,646
Market Cap
6.28B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MDGL News
- 4 days ago - Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis - GlobeNewsWire
- 8 days ago - Madrigal Pharmaceuticals: An Encouraging Start For Rezdiffra - Seeking Alpha
- 13 days ago - Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 15 days ago - Madrigal to Present Late-Breaking Resmetirom Data in Patients with Compensated MASH Cirrhosis at the EASL Congress - GlobeNewsWire
- 26 days ago - Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025 - GlobeNewsWire
- 4 weeks ago - Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D. - GlobeNewsWire
- 2 months ago - Madrigal Appoints Jacqualyn A. Fouse, Ph.D. - GlobeNewsWire